Similarly, antibody conjugates such as the EGFR humanized chimeric monoclonal antibody C225 (cetuximab) conjugated to a benzoprophyrin derivative (verteprofrin) are also non-specific, making selective treatment of bladder cancer challenging32. This evidence concerns the gene EGFR and urinary bladder cancer.